Thyro-Pro T019

FUCUS VESICULOSUS, SPONGIA TOSTA, GLANDULA SUPRARENALIS SUIS, HYPOPHYSIS SUIS, THYROIDINUM (SUIS), BROMIUM, CALCAREA CARBONICA, IODIUM, LACHESIS MUTUS, PULSATILLA (VULGARIS) ORAL HUMAN OTC DRUG

Thyro-Pro T019 is an FDA drug label for the active ingredient FUCUS VESICULOSUS, SPONGIA TOSTA, GLANDULA SUPRARENALIS SUIS, HYPOPHYSIS SUIS, THYROIDINUM (SUIS), BROMIUM, CALCAREA CARBONICA, IODIUM, LACHESIS MUTUS, PULSATILLA (VULGARIS) manufactured by Guangzhou Renuma Medical Systems Co., Ltd administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20171026.

Generic name
FUCUS VESICULOSUS, SPONGIA TOSTA, GLANDULA SUPRARENALIS SUIS, HYPOPHYSIS SUIS, THYROIDINUM (SUIS), BROMIUM, CALCAREA CARBONICA, IODIUM, LACHESIS MUTUS, PULSATILLA (VULGARIS)
Manufacturer
Guangzhou Renuma Medical Systems Co., Ltd
Product type
HUMAN OTC DRUG
Route
ORAL
Dosage form
N/A
NDC
71742-0013
Application
N/A
Label effective
20171026

Active ingredients

ACTIVE INGREDIENTS: Fucus Vesiculosus 3X, Spongia Tosta 3X, Glandula Suprarenalis (Suis) 6X, Hypophysis Suis 6X, Bromium 12X, Calcarea Carbonica 12X, Iodium 12X, Lachesis Mutus 12X, Pulsatilla 12X.

Indications & Usage

INDICATIONS: Thymus support, immune system booster.

Dosage & Administration

DIRECTIONS: Adults and children 5 to 10 drops orally, 3 times daily or as otherwise directed by a health care professional. If symptoms persist, consult your health care professional. Consult a physician for use in children under 12 years of age.

Contraindications

Not available.

Warnings

WARNINGS: If pregnant or breast-feeding, ask a health care professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in cool, dry place.

Adverse Reactions

Not available.